angiotensinconvert
enzym
counterbal
ace
function
neg
regul
reninangiotensin
system
ra
import
ra
acut
respiratori
distress
syndrom
ard
recent
reemerg
owe
identif
receptor
sarscoronaviru
recent
studi
demonstr
protect
mice
acut
lung
injuri
well
sarsmedi
lung
injuri
review
role
ra
particular
pathogenesi
ard
section
editor
terri
delovitch
john
p
robart
angiotensinconvert
enzym
ace
share
homolog
catalyt
domain
provid
differ
key
function
reninangiotensin
system
ra
ace
cleav
angiotensin
ang
gener
angiotensin
ii
ang
ii
wherea
reduc
angiotensin
ii
level
neg
regul
system
import
ra
acut
respiratori
distress
syndrom
ard
recent
reemerg
owe
identif
receptor
sever
acut
respiratori
syndromecoronaviru
sarscov
sar
spread
throughout
world
caus
death
due
ard
studi
demonstr
protect
mice
acut
lung
injuri
well
sarsmedi
lung
injuri
articl
review
role
ra
particular
pathogenesi
ard
possibl
applic
modul
ra
treatment
ard
also
discuss
ard
sever
form
acut
lung
injuri
multipl
predispos
factor
ard
report
includ
sepsi
acid
aspir
trauma
infect
viral
pathogen
sarscov
moreov
recent
avian
influenza
viru
caus
high
lethal
due
ard
despit
recent
progress
mortal
associ
ard
remain
high
pharmacolog
therapi
shown
largescal
trial
impact
mortal
ard
factor
predict
onset
sever
ard
poorli
understood
low
incid
ard
rel
larg
group
patient
risk
shown
also
larg
differ
plasma
ace
concentr
individu
concentr
tend
similar
within
famili
suggest
involv
genet
compon
pathogenesi
ard
human
ace
gene
locat
chromosom
contain
restrict
fragment
length
polymorph
defin
presenc
insert
absenc
delet
alu
repeat
sequenc
intron
nearli
varianc
plasma
ace
activ
account
ace
insertiondelet
id
polymorph
allel
associ
higher
ace
activ
importantli
recent
cohort
studi
ard
show
signific
associ
ace
id
polymorph
suscept
mortal
ard
dd
genotyp
frequenc
increas
patient
ard
compar
control
cohort
ninetysix
patient
fulfil
criteria
ard
genotyp
ace
polymorph
togeth
individu
three
comparison
group
patient
nonard
respiratori
failur
ventil
intens
care
unit
icu
icu
patient
undergo
coronari
arteri
bypass
graft
individu
gener
popul
group
dd
genotyp
frequenc
increas
patient
ard
compar
icu
p
coronari
arteri
bypass
graft
p
gener
popul
group
p
addit
ace
dd
allel
significantli
correl
mortal
ard
group
anoth
studi
show
patient
carri
ace
ii
genotyp
significantli
increas
surviv
rate
studi
mortal
rate
significantli
differ
three
ace
genotyp
ii
id
dd
respect
p
ard
group
taken
togeth
data
suggest
potenti
role
ra
pathogenesi
ard
implic
genet
factor
suscept
progress
syndrom
addit
genet
correl
studi
substanti
clinic
studi
suggest
possibl
activ
ra
patient
ard
instanc
patient
ard
elev
ace
level
bronchoalveolar
lavag
fluid
observ
despit
reduct
circul
ace
reduc
circul
ace
level
may
reflect
loss
enzym
releas
damag
pulmonari
vascular
endothelium
may
repres
activ
lung
compart
also
report
pulmonari
capillari
endotheliumbound
pceb
ace
activ
correl
sever
lung
injuri
patient
acut
lung
injuri
data
suggest
possibl
activ
ra
patient
ard
interestingli
recent
retrospect
epidemiolog
studi
demonstr
prior
outpati
use
ace
inhibitor
associ
decreas
mortal
patient
hospit
communityacquir
pneumonia
although
studi
need
examin
whether
ace
inhibitor
protect
use
inpati
set
patient
lack
tradit
indic
use
medic
novel
homologu
ace
clone
term
ace
share
homolog
catalyt
domain
provid
differ
key
function
ra
ace
cleav
angiotensin
gener
angiotensin
ii
wherea
reduc
angiotensin
ii
level
biolog
effect
ang
ii
mediat
two
specif
receptor
ang
ii
receptor
type
r
ang
ii
receptor
type
r
target
disrupt
murin
result
increas
ang
ii
level
impair
cardiac
contractil
age
mice
upregul
hypoxiainduc
gene
heart
worsen
heart
failur
follow
aortic
band
loss
ace
background
pharmacolog
inhibit
ra
least
partial
revers
cardiac
phenotyp
genet
data
demonstr
counterbal
function
ace
neg
regul
ang
ii
level
within
ra
fig
group
investig
role
ard
use
knockout
mice
acid
aspirationinduc
ard
endotoxininduc
ard
well
periton
sepsisinduc
ard
knockout
mice
exhibit
sever
diseas
compar
control
mice
express
loss
express
mutant
mice
also
result
enhanc
vascular
permeabl
increas
lung
edema
neutrophil
accumul
worsen
lung
function
note
patholog
manifest
occur
without
appar
chang
heart
contractil
pulmonari
vascular
tone
among
experiment
group
mechanist
neg
regul
ang
ii
level
account
part
protect
function
ard
exampl
inhibitor
treatment
addit
ace
gene
defici
knockout
background
rescu
sever
phenotyp
singl
mutant
mice
acut
lung
injuri
addit
ace
knockout
mice
r
knockout
mice
r
knockout
mice
show
improv
symptom
acut
lung
injuri
therefor
acut
lung
injuri
ace
ang
ii
r
promot
acut
lung
injuri
wherea
r
figur
current
view
reninangiotensin
system
angiotensin
serv
substrat
ace
angiotensin
ii
known
act
vasoconstrictor
well
mitogen
smooth
muscl
cell
fibroblast
mainli
angiotensin
ii
type
receptor
function
angiotensin
well
understood
ace
involv
product
vasodil
peptid
angiotensin
protect
lung
injuri
importantli
treatment
catalyt
activ
enzymat
inact
recombin
protein
improv
symptom
acut
lung
injuri
wild
type
mice
well
knockout
mice
suggest
protein
possibl
novel
therapeut
target
ard
fig
within
month
follow
public
sarscov
genom
identifi
potenti
receptor
cell
line
studi
vitro
bind
sarscov
spike
support
syncytia
format
fusion
spikeprotein
express
cell
larg
multinucl
cell
also
seen
real
sar
infect
use
mous
sar
infect
model
knockout
mice
group
provid
evid
inde
essenti
sar
infect
vivo
knockout
mice
infect
sar
coronaviru
resist
viru
infect
viru
titer
lung
tissu
infect
knockout
mice
fold
lower
isol
lung
sarscovinfect
wild
type
mice
thu
without
exclud
second
function
sarscov
receptor
essenti
receptor
sar
infect
vivo
despit
mani
studi
sarscov
one
mysteri
sarscov
contrast
coronavirus
infect
sarscov
trigger
sever
lung
diseas
high
mortal
accumul
evid
indic
sever
sar
infect
depend
burden
viral
replic
well
immunopatholog
consequ
host
respons
studi
implic
involv
ra
sar
pathogenesi
intriguingli
wild
type
mice
infect
sarscov
show
markedli
downregul
express
lung
similarli
treatment
recombin
sarsspik
protein
absenc
viru
compon
downregul
express
vitro
vivo
thu
sarscovinfect
spike
proteintr
wild
type
mice
resembl
knockout
mice
similar
mutant
mice
spiketr
wild
type
mice
show
markedli
sever
patholog
acut
lung
injuri
addit
spiketr
mice
ang
ii
peptid
level
increas
worsen
ard
symptom
could
partial
revers
r
blocker
treatment
thu
downregul
express
sarscov
infect
might
play
causal
role
sar
pathogenesi
especi
diseas
progress
ard
pulmonari
circul
potenti
import
target
ra
activ
lung
instanc
ang
ii
via
type
receptor
r
induc
pulmonari
vasoconstrict
respons
hypoxia
suggest
import
role
r
elev
pulmonari
vascular
tone
result
pulmonari
edema
also
infus
ang
ang
ii
produc
pulmonari
edema
independ
catecholamin
releas
data
suggest
import
role
ra
regul
pulmonari
vascular
tone
might
also
contribut
pathogenesi
ard
addit
increas
vascular
tone
subsequ
hydostat
edema
format
accumul
data
suggest
ang
ii
also
increas
vascular
permeabl
via
r
wherea
stimul
receptor
exert
opposit
effect
sever
mediat
implic
ang
ii
regul
vascular
permeabl
chang
includ
eicosanoid
ie
leukotrien
c
prostaglandin
e
vascular
permeabl
factor
howev
rel
studi
address
whether
ra
involv
increas
vascular
permeabl
observ
ard
studi
demonstr
loss
result
increas
vascular
permeabl
use
evan
vol
drug
discoveri
today
diseas
mechan
immunodisord
autoimmun
figur
schemat
diagram
propos
role
reninangiotensin
system
develop
ard
ard
induc
sarscov
infect
acid
aspir
pneumonia
sepsi
pathogen
condit
gener
ang
ii
ang
mediat
ace
ang
ii
contribut
acut
lung
failur
stimul
angiotensin
ii
type
receptor
r
wherea
angiotensin
ii
type
receptor
r
neg
regul
pathway
protect
acut
lung
failur
howev
addit
ang
iiindepend
pathway
seem
also
contribut
ard
wwwdrugdiscoverytodaycom
blue
dye
inject
vivo
indic
albumin
leakag
mice
vascular
permeabl
significantli
attenu
lung
r
mutant
mice
data
indic
loss
express
increas
ang
ii
level
trigger
leaki
pulmonari
blood
vessel
r
stimul
ard
ace
unspecif
proteas
cleav
addit
substrat
might
also
play
import
role
ard
independ
ang
ii
one
ace
target
bradykinin
peptid
metabolit
bradykinin
key
effect
kallikreinkinin
system
also
function
major
proinflammatori
mediat
bradykinin
degrad
two
main
kinas
ace
also
known
kinas
ii
system
neutral
endopeptidas
biolog
effect
bradykinin
mediat
receptor
b
r
receptor
b
r
b
r
mediat
known
effect
bradykinin
includ
antiprolif
antioxid
antithrombot
effect
vivo
effect
mediat
via
b
r
b
r
still
poorli
character
recent
studi
suggest
express
b
r
induc
cytokin
inflamm
rat
albeit
role
bradykinin
ang
iiinduc
inflamm
remain
unclear
remov
vitro
assay
ctermin
residu
apelin
vasoact
peptid
neurotensin
neurotensinrel
peptid
kinetensin
moreov
opioid
peptid
dynorphin
bcasamorphin
also
substrat
contrast
ace
metabol
bradykinin
catalyt
inactiv
desarg
bradykinin
ly
desarg
bradykinin
thu
although
mani
function
attribut
regul
ang
ii
level
ang
ii
probabl
part
stori
substrat
might
play
major
role
understand
function
importantli
preliminari
result
suggest
inhibit
bradykinin
receptor
also
allevi
ard
yi
jmp
unpublish
recent
critic
import
ra
pathogenesi
ard
establish
genet
anim
model
protect
murin
lung
acut
lung
injuri
induc
acid
aspir
endotoxin
shock
periton
sepsi
addit
ace
knockout
mice
r
knockout
mice
r
knockout
mice
show
improv
symptom
acut
lung
injuri
consist
experiment
studi
also
identifi
key
sarscov
receptor
importantli
play
protect
role
sarscovmedi
lung
injuri
therefor
acut
lung
injuri
ace
ang
ii
r
promot
acut
lung
injuri
wherea
r
protect
lung
injuri
find
might
provid
opportun
develop
recombin
novel
drug
ard
along
r
inhibitor
ace
inhibitor
possibl
treat
emerg
infecti
lung
diseas
avian
influenza
diseas
affect
lung
function
tabl
addit
unspecif
proteas
would
also
interest
investig
role
metabolit
includ
angiotensin
desarg
bradykinin
apelin
dynorphin
ard
look
forward
use
angiotensin
systemmodul
agentsmolecul
particular
novel
therapeut
agent
treat
sever
acut
lung
failur
syndrom
affect
million
peopl
without
yet
effect
drug
treatment
report
studi
refer
vivo
mous
angiotensin
ii
receptor
type
r
inhibitor
human
vivo
mous
vivo
rat
angiotensin
convert
enzym
ace
inhibitor
vivo
mous
vivo
rat
